Mutations in presenilin-1 (PS1), the leading cause of early-onset, autosomal-dominant familial Alzheimer's disease (FAD), enhance calcium signaling mediated by inositol 1,4,5-trisphosphate (IP 3 ). To elucidate the subcellular mechanisms underlying this enhancement, we used high resolution linescanning confocal microscopy to image elementary calcium release events ("puffs") in Xenopus oocytes expressing wild-type or mutant PS1. Here we report that mutant PS1-rendered puffs more sensitive to IP 3 and increased both the magnitude and the rate of calcium release during each event. These effects were not attributable to quantitative changes in the levels of IP 3 receptors or their distribution on the ER, but were instead associated with an abnormal elevation of ER calcium stores. Together, our results suggest that the effects of mutant PS1 on calcium signaling are manifested predominantly at the level of the regulation of calcium stores rather than via perturbations in the numbers or activity of IP 3 -activated calcium release channels.
INTRODUCTION
Presenilin 1 and 2 (PS1, PS2) are highly conserved, pleiotropic proteins localized predominantly to the endoplasmic reticulum (Kovacs et al., 1996; Weber et al., 1997; Zhang et al., 1998) . Mutations in the presenilins cause a number of cellular defects implicated in the pathogenesis of Alzheimer's disease, including altered ␥-secretase-mediated cleavage of the ␤-amyloid precursor protein (APP) and dysregulation of intracellular calcium signaling pathways (for reviews see Mattson et al., 2000a; Selkoe, 1999) . Although the mechanisms by which presenilin mutations lead to APP mismetabolism have been extensively studied, relatively little is known about the precise subcellular disturbances underlying the effects of presenilin mutations on calcium dyshomeostasis.
Like effects on APP processing, calcium signaling alterations appear to be an early and invariant consequence of presenilin mutations, having been documented for multiple mutations in PS1 and PS2 in numerous experimental systems (Barrow et al., 2000; Etcheberrigaray et al., 1998; Gibson et al., 1996; Hirashima et al., 1996; Ito et al., 1994; Keller et al., 1998; Leissring et al., 2000a; Leissring et al., 1999a; Leissring et al., 1999b Leissring et al., , 2000b Mattson et al., 2000b; Parent et al., 1999) . For instance, even prior to the identification of the presenilins, calcium alterations were described in skin fibroblasts from a family of chromosome 14-linked FAD patients, who were later shown to harbor the A246Q mutation in PS1 (Ito et al., 1994) . Intriguingly, these perturbations in calcium signaling are so selective and so consistent that they can be used to reliably predict FAD several years prior to presentation of overt neurological symptoms (Etcheberrigaray et al., 1998) . Recently, we demonstrated that nearly identical disturbances are present in fibroblasts from mutant PS1 M146V knock-in animals (Leissring et al., 2000a) ,
